SG11201607750PA - Cyano containing azabenzofuran compounds for the treatment of hepatitis c - Google Patents
Cyano containing azabenzofuran compounds for the treatment of hepatitis cInfo
- Publication number
- SG11201607750PA SG11201607750PA SG11201607750PA SG11201607750PA SG11201607750PA SG 11201607750P A SG11201607750P A SG 11201607750PA SG 11201607750P A SG11201607750P A SG 11201607750PA SG 11201607750P A SG11201607750P A SG 11201607750PA SG 11201607750P A SG11201607750P A SG 11201607750PA
- Authority
- SG
- Singapore
- Prior art keywords
- hepatitis
- treatment
- cyano containing
- azabenzofuran
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4355—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461968763P | 2014-03-21 | 2014-03-21 | |
PCT/US2015/021638 WO2015143255A1 (en) | 2014-03-21 | 2015-03-20 | Cyano containing azabenzofuran compounds for the treatment of hepatitis c |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201607750PA true SG11201607750PA (en) | 2016-10-28 |
Family
ID=52808191
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201607750PA SG11201607750PA (en) | 2014-03-21 | 2015-03-20 | Cyano containing azabenzofuran compounds for the treatment of hepatitis c |
Country Status (18)
Country | Link |
---|---|
US (1) | US9249152B2 (es) |
EP (1) | EP3119785B1 (es) |
JP (1) | JP2017509700A (es) |
KR (1) | KR20160126085A (es) |
CN (1) | CN106459070A (es) |
AR (1) | AR099820A1 (es) |
AU (1) | AU2015231139A1 (es) |
CA (1) | CA2943526A1 (es) |
CL (1) | CL2016002361A1 (es) |
EA (1) | EA201691777A1 (es) |
ES (1) | ES2688554T3 (es) |
IL (1) | IL247830A0 (es) |
MX (1) | MX2016012104A (es) |
PE (1) | PE20161224A1 (es) |
SG (1) | SG11201607750PA (es) |
TW (1) | TW201620914A (es) |
WO (1) | WO2015143255A1 (es) |
ZA (1) | ZA201606478B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3119769A1 (en) * | 2014-03-21 | 2017-01-25 | Bristol-Myers Squibb Pharma Company | Cyanoamino (aza)benzofuran compounds for the treatment of hepatitis c |
AU2016367147B2 (en) * | 2015-12-07 | 2021-04-08 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0315937A (pt) | 2002-11-01 | 2005-09-13 | Viropharma Inc | Composto, composição para a profilaxia ou tratamento de infecções virais, e, método para a profilaxia ou tratamento de infecções da hepatite c e doenças associadas com tais infecções em um hospedeiro vivo |
JP2011512341A (ja) | 2008-02-14 | 2011-04-21 | エフ.ホフマン−ラ ロシュ アーゲー | 抗ウイルス性複素環化合物 |
US7994171B2 (en) * | 2008-09-11 | 2011-08-09 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US8198449B2 (en) * | 2008-09-11 | 2012-06-12 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US8048887B2 (en) * | 2008-09-11 | 2011-11-01 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
WO2011112186A1 (en) * | 2010-03-10 | 2011-09-15 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis c |
KR101594166B1 (ko) | 2010-10-26 | 2016-02-15 | 프레시디오 파마슈티칼스, 인코포레이티드 | C형 간염 바이러스의 억제제 |
-
2015
- 2015-03-20 PE PE2016001648A patent/PE20161224A1/es not_active Application Discontinuation
- 2015-03-20 ES ES15714137.5T patent/ES2688554T3/es active Active
- 2015-03-20 SG SG11201607750PA patent/SG11201607750PA/en unknown
- 2015-03-20 EA EA201691777A patent/EA201691777A1/ru unknown
- 2015-03-20 CN CN201580024715.3A patent/CN106459070A/zh active Pending
- 2015-03-20 AR ARP150100859A patent/AR099820A1/es unknown
- 2015-03-20 MX MX2016012104A patent/MX2016012104A/es unknown
- 2015-03-20 EP EP15714137.5A patent/EP3119785B1/en not_active Not-in-force
- 2015-03-20 CA CA2943526A patent/CA2943526A1/en not_active Abandoned
- 2015-03-20 AU AU2015231139A patent/AU2015231139A1/en not_active Abandoned
- 2015-03-20 KR KR1020167028891A patent/KR20160126085A/ko unknown
- 2015-03-20 US US14/663,497 patent/US9249152B2/en active Active
- 2015-03-20 TW TW104109071A patent/TW201620914A/zh unknown
- 2015-03-20 JP JP2017501122A patent/JP2017509700A/ja active Pending
- 2015-03-20 WO PCT/US2015/021638 patent/WO2015143255A1/en active Application Filing
-
2016
- 2016-09-15 IL IL247830A patent/IL247830A0/en unknown
- 2016-09-20 CL CL2016002361A patent/CL2016002361A1/es unknown
- 2016-09-20 ZA ZA2016/06478A patent/ZA201606478B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EA201691777A1 (ru) | 2016-12-30 |
CL2016002361A1 (es) | 2017-04-21 |
ES2688554T3 (es) | 2018-11-05 |
AU2015231139A1 (en) | 2016-11-03 |
KR20160126085A (ko) | 2016-11-01 |
PE20161224A1 (es) | 2016-11-12 |
CA2943526A1 (en) | 2015-09-24 |
US20150266886A1 (en) | 2015-09-24 |
TW201620914A (zh) | 2016-06-16 |
WO2015143255A1 (en) | 2015-09-24 |
US9249152B2 (en) | 2016-02-02 |
EP3119785A1 (en) | 2017-01-25 |
AR099820A1 (es) | 2016-08-17 |
IL247830A0 (en) | 2016-11-30 |
JP2017509700A (ja) | 2017-04-06 |
ZA201606478B (en) | 2018-05-30 |
MX2016012104A (es) | 2016-12-09 |
CN106459070A (zh) | 2017-02-22 |
EP3119785B1 (en) | 2018-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL280459A (en) | Phosphoramidates for the treatment of hepatitis B virus | |
HK1247202A1 (zh) | 用於治療癌症的化合物 | |
HRP20181772T1 (hr) | Spoj za obradu gnojiva koje sadrži ureu | |
HK1244276A1 (zh) | 用於治療hiv的稠合嘧啶化合物 | |
HK1246776A1 (zh) | 用於hiv治療的異喹啉化合物 | |
DK3148529T3 (da) | Forbindelser til behandling af hjernecancer | |
IL285077A (en) | Compounds for the treatment of cancer | |
GB201415569D0 (en) | Therapeutic Compounds | |
HK1232220A1 (zh) | 用於治療心血管疾病的 -苄基異喹啉衍生物 | |
GB201416273D0 (en) | Therapeutic compounds | |
SG11201702700UA (en) | Methods for the treatment of peri-implantitis | |
ZA201606478B (en) | Cyano containing azabenzofuran compounds for the treatment of hepatitis c | |
ZA201704589B (en) | Compounds for the treatment of cancer | |
GB201512635D0 (en) | Uses of therapeutic compounds | |
GB201418513D0 (en) | Compounds for the treatment of muscular dystrophy having improved bioavailability | |
GB201409405D0 (en) | Therapeutic compounds | |
GB201407122D0 (en) | Therapeutic compounds | |
GB201406748D0 (en) | Therapeutic compounds |